{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:28:07Z","timestamp":1778074087214,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02300-2","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T22:18:57Z","timestamp":1742854737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["RETRACTED ARTICLE: Circular RNA circDCUN1D4\n            suppresses hepatocellular carcinoma development via targeting the miR-590-5p\/ TIMP3\n            axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"2300_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet.\n                    2018;391:1301\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(18)30010-2.","journal-title":"Lancet"},{"key":"2300_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, et al. Global epidemiology and genetics of hepatocellular\n                    carcinoma. Gastroenterology. 2023;164:766\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033.","journal-title":"Gastroenterology"},{"key":"2300_CR3","doi-asserted-by":"publisher","unstructured":"Vo JN et al. The Landscape of Circular RNA in Cancer. Cell 176,\n                    869\u2013881 e813. https:\/\/doi.org\/10.1016\/j.cell.2018.12.021 (2019).","DOI":"10.1016\/j.cell.2018.12.021"},{"key":"2300_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-019-1046-7","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, et al. Circular RNA circRHOT1 promotes hepatocellular\n                    carcinoma progression by initiation of NR2F6 expression. Mol Cancer.\n                    2019;18:119. https:\/\/doi.org\/10.1186\/s12943-019-1046-7.","journal-title":"Mol Cancer"},{"key":"2300_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han D, et al. Circular RNA circMTO1 acts as the sponge of\n                    microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology.\n                    2017;66:1151\u201364. https:\/\/doi.org\/10.1002\/hep.29270.","journal-title":"Hepatology"},{"key":"2300_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-020-01221-6","volume":"19","author":"N Zhang","year":"2020","unstructured":"Zhang N, et al. Circular RNA circSATB2 promotes progression of\n                    non-small cell lung cancer cells. Mol Cancer. 2020;19:101. https:\/\/doi.org\/10.1186\/s12943-020-01221-6.","journal-title":"Mol Cancer"},{"key":"2300_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, et al. circNDUFB2 inhibits non-small cell lung cancer\n                    progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat\n                    Commun. 2021;12:295. https:\/\/doi.org\/10.1038\/s41467-020-20527-z.","journal-title":"Nat Commun"},{"key":"2300_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/0008-5472.CAN-22-1923","volume":"83","author":"Y Shen","year":"2023","unstructured":"Shen Y, et al. CircPDIA4 induces gastric cancer progression by\n                    promoting ERK1\/2 activation and enhancing biogenesis of oncogenic circrnas.\n                    Cancer Res. 2023;83:538\u201352. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1923.","journal-title":"Cancer Res"},{"key":"2300_CR9","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ymthe.2023.04.013","volume":"31","author":"H Liu","year":"2023","unstructured":"Liu H, et al. Circular MTHFD2L RNA-encoded CM-248aa inhibits\n                    gastric cancer progression by targeting the SET-PP2A interaction. Mol Ther.\n                    2023;31:1739\u201355. https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.013.","journal-title":"Mol Ther"},{"key":"2300_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/cdd.2017.86","volume":"24","author":"Q Yang","year":"2017","unstructured":"Yang Q, et al. A circular RNA promotes tumorigenesis by inducing\n                    c-myc nuclear translocation. Cell Death Differ. 2017;24:1609\u201320. https:\/\/doi.org\/10.1038\/cdd.2017.86.","journal-title":"Cell Death Differ"},{"key":"2300_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2019.05.036","volume":"459","author":"L Fang","year":"2019","unstructured":"Fang L, Du WW, Awan FM, Dong J, Yang BB. The circular RNA\n                    circ-Ccnb1 dissociates Ccnb1\/Cdk1 complex suppressing cell invasion and\n                    tumorigenesis. Cancer Lett. 2019;459:216\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.036.","journal-title":"Cancer Lett"},{"key":"2300_CR12","doi-asserted-by":"publisher","first-page":"e56102","DOI":"10.15252\/embr.202256102","volume":"23","author":"Y Li","year":"2022","unstructured":"Li Y, et al. CircHIPK3 sponges miR-558 to suppress heparanase\n                    expression in bladder cancer cells. EMBO Rep. 2022;23:e56102. https:\/\/doi.org\/10.15252\/embr.202256102.","journal-title":"EMBO Rep"},{"key":"2300_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-018-0771-7","volume":"17","author":"C Yang","year":"2018","unstructured":"Yang C, et al. Circular RNA circ-ITCH inhibits bladder cancer\n                    progression by sponging miR-17\/miR-224 and regulating p21, PTEN expression. Mol\n                    Cancer. 2018;17:19. https:\/\/doi.org\/10.1186\/s12943-018-0771-7.","journal-title":"Mol Cancer"},{"key":"2300_CR14","doi-asserted-by":"publisher","unstructured":"Long F, et al. Comprehensive landscape and future perspectives of\n                    circular RNAs in colorectal cancer. Mol Cancer. 2021;20. https:\/\/doi.org\/10.1186\/s12943-021-01318-6.","DOI":"10.1186\/s12943-021-01318-6"},{"key":"2300_CR15","doi-asserted-by":"publisher","first-page":"e3171","DOI":"10.1038\/cddis.2017.556","volume":"8","author":"L Shi","year":"2017","unstructured":"Shi L, et al. Circular RNA expression is suppressed by androgen\n                    receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human\n                    hepatocellular carcinoma. Cell Death Dis. 2017;8:e3171. https:\/\/doi.org\/10.1038\/cddis.2017.556.","journal-title":"Cell Death Dis"},{"key":"2300_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in cancer:\n                    biogenesis, function, and clinical significance. Trends Cancer.\n                    2020;6:319\u201336. https:\/\/doi.org\/10.1016\/j.trecan.2020.01.012.","journal-title":"Trends Cancer"},{"key":"2300_CR17","doi-asserted-by":"publisher","first-page":"e17119","DOI":"10.1016\/j.heliyon.2023.e17119","volume":"9","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, et al. Single-cell transcriptome analysis reveals T\n                    population heterogeneity and functions in tumor microenvironment of colorectal\n                    cancer metastases. Heliyon. 2023;9:e17119. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17119.","journal-title":"Heliyon"},{"key":"2300_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omtn.2020.11.012","volume":"23","author":"Y Liang","year":"2021","unstructured":"Liang Y, et al. circDCUN1D4 suppresses tumor metastasis and\n                    Glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Mol Ther\n                    Nucleic Acids. 2021;23:355\u201368. https:\/\/doi.org\/10.1016\/j.omtn.2020.11.012.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2300_CR19","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/onc.2014.339","volume":"34","author":"V Defamie","year":"2015","unstructured":"Defamie V, Sanchez O, Murthy A, Khokha R. TIMP3 controls cell fate\n                    to confer hepatocellular carcinoma resistance. Oncogene.\n                    2015;34:4098\u2013108. https:\/\/doi.org\/10.1038\/onc.2014.339.","journal-title":"Oncogene"},{"key":"2300_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.omtn.2022.08.008","volume":"29","author":"H Liu","year":"2022","unstructured":"Liu H, et al. Circular RNA circSFMBT2 downregulation by HBx\n                    promotes hepatocellular carcinoma metastasis via the miR-665\/TIMP3 axis. Mol\n                    Ther Nucleic Acids. 2022;29:788\u2013802. https:\/\/doi.org\/10.1016\/j.omtn.2022.08.008.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2300_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, et al. Circular RNA cSMARCA5 inhibits growth and metastasis\n                    in hepatocellular carcinoma. J Hepatol. 2018;68:1214\u201327. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.012.","journal-title":"J Hepatol"},{"key":"2300_CR22","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1038\/s41388-021-01873-8","volume":"40","author":"X Bi","year":"2021","unstructured":"Bi X, et al. Msi1 promotes breast cancer metastasis by regulating\n                    invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9\n                    pathway. Oncogene. 2021;40:4832\u201345. https:\/\/doi.org\/10.1038\/s41388-021-01873-8.","journal-title":"Oncogene"},{"key":"2300_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41419-019-1841-5","volume":"10","author":"Q Sun","year":"2019","unstructured":"Sun Q, et al. A novel MiRNA identified in GRSF1 complex drives the\n                    metastasis via the PIK3R3\/AKT\/NF-kappaB and TIMP3\/MMP9 pathways in cervical\n                    cancer cells. Cell Death Dis. 2019;10:636. https:\/\/doi.org\/10.1038\/s41419-019-1841-5.","journal-title":"Cell Death Dis"},{"key":"2300_CR24","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix\n                    metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur J\n                    Med Chem. 2020;194:112260. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112260.","journal-title":"Eur J Med Chem"},{"key":"2300_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/0008-5472.CAN-23-0151","volume":"83","author":"JH McCarty","year":"2023","unstructured":"McCarty JH. MMP9 clears the way for metastatic cell penetration\n                    across the Blood-Brain barrier. Cancer Res. 2023;83:1167\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0151.","journal-title":"Cancer Res"},{"key":"2300_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.placenta.2024.09.018","volume":"158","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Ross K, Sekar D. The emerging role of\n                    microRNA-based therapeutics in the treatment of preeclampsia. Placenta.\n                    2024;158:38\u201347. https:\/\/doi.org\/10.1016\/j.placenta.2024.09.018.","journal-title":"Placenta"},{"key":"2300_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.placenta.2024.05.135","volume":"153","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Sekar D. MicroRNA-510-3p regulated\n                    vascular dysfunction in preeclampsia by targeting vascular endothelial growth\n                    factor A (VEGFA) and its signaling axis. Placenta. 2024;153:31\u201352. https:\/\/doi.org\/10.1016\/j.placenta.2024.05.135.","journal-title":"Placenta"},{"key":"2300_CR28","doi-asserted-by":"publisher","unstructured":"Yu T, et al. CircRNAs in cancer metabolism: a review. J Hematol\n                    Oncol. 2019;12. https:\/\/doi.org\/10.1186\/s13045-019-0776-8.","DOI":"10.1186\/s13045-019-0776-8"},{"key":"2300_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du A, et al. M6A-mediated upregulation of circmdk promotes\n                    tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.\n                    Mol Cancer. 2022;21:109. https:\/\/doi.org\/10.1186\/s12943-022-01575-z.","journal-title":"Mol Cancer"},{"key":"2300_CR30","doi-asserted-by":"publisher","first-page":"100413","DOI":"10.1016\/j.jhepr.2021.100413","volume":"4","author":"C Louis","year":"2022","unstructured":"Louis C, Leclerc D, Coulouarn C. Emerging roles of circular RNAs in\n                    liver cancer. JHEP Rep. 2022;4:100413. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100413.","journal-title":"JHEP Rep"},{"key":"2300_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-022-01619-4","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, et al. CircGPR137B\/miR-4739\/FTO feedback loop suppresses\n                    tumorigenesis and metastasis of hepatocellular carcinoma. Mol Cancer.\n                    2022;21:149. https:\/\/doi.org\/10.1186\/s12943-022-01619-4.","journal-title":"Mol Cancer"},{"key":"2300_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1158\/0008-5472.CAN-21-1259","volume":"82","author":"J Li","year":"2022","unstructured":"Li J, et al. CircRPN2 inhibits aerobic Glycolysis and metastasis in\n                    hepatocellular carcinoma. Cancer Res. 2022;82:1055\u201369. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1259.","journal-title":"Cancer Res"},{"key":"2300_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-021-03545-7","volume":"12","author":"G Liu","year":"2021","unstructured":"Liu G, et al. Cancer-associated fibroblast-derived CXCL11 modulates\n                    hepatocellular carcinoma cell migration and tumor metastasis through the\n                    circUBAP2\/miR-4756\/IFIT1\/3 axis. Cell Death Dis. 2021;12:260. https:\/\/doi.org\/10.1038\/s41419-021-03545-7.","journal-title":"Cell Death Dis"},{"key":"2300_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.ymthe.2021.01.018","volume":"29","author":"Q Yang","year":"2021","unstructured":"Yang Q, Li F, He AT, Yang BB. Circular RNAs: expression,\n                    localization, and therapeutic potentials. Mol Ther. 2021;29:1683\u2013702. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.018.","journal-title":"Mol Ther"},{"key":"2300_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omtn.2021.05.022","volume":"25","author":"AR Sharma","year":"2021","unstructured":"Sharma AR, et al. Recent research progress on circular RNAs:\n                    biogenesis, properties, functions, and therapeutic potential. Mol Ther Nucleic\n                    Acids. 2021;25:355\u201371. https:\/\/doi.org\/10.1016\/j.omtn.2021.05.022.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2300_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40164-023-00451-w","volume":"12","author":"XY Feng","year":"2023","unstructured":"Feng XY, et al. New insight into circrnas: characterization,\n                    strategies, and biomedical applications. Exp Hematol Oncol. 2023;12:91. https:\/\/doi.org\/10.1186\/s40164-023-00451-w.","journal-title":"Exp Hematol Oncol"},{"key":"2300_CR37","doi-asserted-by":"publisher","unstructured":"Cabral-Pacheco GA, et al. The roles of matrix metalloproteinases\n                    and their inhibitors in human diseases. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21249739.","DOI":"10.3390\/ijms21249739"},{"key":"2300_CR38","doi-asserted-by":"publisher","first-page":"106846","DOI":"10.1016\/j.phrs.2023.106846","volume":"194","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. Targeting of HBP1\/TIMP3 axis as a novel strategy\n                    against breast cancer. Pharmacol Res. 2023;194:106846. https:\/\/doi.org\/10.1016\/j.phrs.2023.106846.","journal-title":"Pharmacol Res"},{"key":"2300_CR39","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, et al. The deubiquitinase USP10 regulates KLF4 stability\n                    and suppresses lung tumorigenesis. Cell Death Differ. 2020;27:1747\u201364. https:\/\/doi.org\/10.1038\/s41418-019-0458-7.","journal-title":"Cell Death Differ"},{"key":"2300_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc.2016.115","volume":"17","author":"HW Jackson","year":"2017","unstructured":"Jackson HW, Defamie V, Waterhouse P, Khokha R. TIMPs: versatile\n                    extracellular regulators in cancer. Nat Rev Cancer. 2017;17:38\u201353. https:\/\/doi.org\/10.1038\/nrc.2016.115.","journal-title":"Nat Rev Cancer"},{"key":"2300_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.120.045765","volume":"142","author":"L Yang","year":"2020","unstructured":"Yang L, et al. Extracellular Vesicle-Mediated delivery of circular\n                    RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic\n                    stroke models. Circulation. 2020;142:556\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045765.","journal-title":"Circulation"},{"key":"2300_CR42","doi-asserted-by":"publisher","first-page":"e10835","DOI":"10.15252\/emmm.201910835","volume":"11","author":"H Li","year":"2019","unstructured":"Li H, et al. Therapeutic targeting of circ-CUX1\/EWSR1\/MAZ axis\n                    inhibits Glycolysis and neuroblastoma progression. EMBO Mol Med. 2019;11:e10835. https:\/\/doi.org\/10.15252\/emmm.201910835.","journal-title":"EMBO Mol Med"},{"key":"2300_CR43","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.18632\/aging.204805","volume":"15","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. HucMSCs treatment prevents pulmonary fibrosis by\n                    reducing circANKRD42-YAP1-mediated mechanical stiffness. Aging.\n                    2023;15:5514\u201334. https:\/\/doi.org\/10.18632\/aging.204805.","journal-title":"Aging"},{"key":"2300_CR44","doi-asserted-by":"publisher","first-page":"e13297","DOI":"10.1111\/cpr.13297","volume":"56","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. N(6) -methyladenosine-modified circrna RERE modulates\n                    osteoarthritis by regulating beta-catenin ubiquitination and degradation. Cell\n                    Prolif. 2023;56:e13297. https:\/\/doi.org\/10.1111\/cpr.13297.","journal-title":"Cell Prolif"},{"key":"2300_CR45","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, et al. A Tumor-suppressive molecular axis\n                    EP300\/circRERE\/miR-6837-3p\/MAVS activates type I IFN pathway and antitumor\n                    immunity to suppress colorectal cancer. Clin Cancer Res.\n                    2023;29:2095\u2013109. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3836.","journal-title":"Clin Cancer Res"},{"key":"2300_CR46","doi-asserted-by":"publisher","first-page":"e2205692","DOI":"10.1002\/advs.202205692","volume":"10","author":"L Fan","year":"2023","unstructured":"Fan L, et al. Exosome-Based mitochondrial delivery of circrna mSCAR\n                    alleviates sepsis by orchestrating macrophage activation. Adv Sci (Weinh).\n                    2023;10:e2205692. https:\/\/doi.org\/10.1002\/advs.202205692.","journal-title":"Adv Sci (Weinh)"},{"key":"2300_CR47","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, et al. Circular RNA cancer vaccines drive immunity in\n                    hard-to-treat malignancies. Theranostics. 2022;12:6422\u201336. https:\/\/doi.org\/10.7150\/thno.77350.","journal-title":"Theranostics"},{"key":"2300_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00650-8","author":"Z Feng","year":"2023","unstructured":"Feng Z, et al. An in vitro-transcribed circular RNA targets the\n                    mitochondrial inner membrane Cardiolipin to ablate\n                    EIF4G2(+)\/PTBP1(+) pan-adenocarcinoma. Nat Cancer. 2023. https:\/\/doi.org\/10.1038\/s43018-023-00650-8.","journal-title":"Nat Cancer"},{"key":"2300_CR49","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ymthe.2019.05.011","volume":"27","author":"Y Sang","year":"2019","unstructured":"Sang Y, et al. circRNA_0025202 regulates Tamoxifen sensitivity and\n                    tumor progression via regulating the miR-182-5p\/FOXO3a axis in breast cancer.\n                    Mol Ther. 2019;27:1638\u201352. https:\/\/doi.org\/10.1016\/j.ymthe.2019.05.011.","journal-title":"Mol Ther"},{"key":"2300_CR50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, et al. CircRNA-SORE mediates Sorafenib resistance in\n                    hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther.\n                    2020;5:298. https:\/\/doi.org\/10.1038\/s41392-020-00375-5.","journal-title":"Signal Transduct Target Ther"}],"updated-by":[{"DOI":"10.1186\/s12943-025-02550-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02300-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:32:18Z","timestamp":1767699138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02300-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02300-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12943-025-02550-0","URL":"https:\/\/doi.org\/10.1186\/s12943-025-02550-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of\n                    Southwest Hospital (Chongqing, China) under approval numbers 2020-CQC-FWK-002\n                    (human HCC study) and AUCC-2024-196 (animal experimental procedures). All\n                    experiments involving human subjects were conducted in accordance with the\n                    Declaration of Helsinki and relevant institutional guidelines. Written informed\n                    consent was obtained from all participating HCC patients prior to their\n                    inclusion in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of this\n                    manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}